What is the EU Joint Clinical Assessment (JCA) and what does it mean for market access and reimbursment in Euorpe?
-
Mtech Access
A purpose-built pharmaceutical-services platform, Petauri is actively partnering with best-in-class companies recognised for their expertise in global market access, health systems, medical affairs, HEOR, patient services, and data and analytics.
As part of Petauri, Mtech Access will offer broader expertise to seamlessly support our valued clients with impactful solutions that speed patient access to life-changing care. Find more details here.
We partner with market access and HEOR teams across all global and local milestones, providing the strategy, insight, evidence, and materials to ensure commercial success.
Phase 2
Outcome: Decision-making and the foundations of future market access supported by evidence and strategic insight.
Phase 2-3
Outcome: A comprehensive strategy for global market access that is driven by market, competitor, and payer insights.
Phase 3 to launch
Outcome: Impactful messaging, value materials, and evidence ready for local affiliates launches.
Phase 3 to launch and beyond
Outcome: Robust HTA strategies and submissions to secure approval in these key markets.
Outcome: Comprehensive local market access strategy and engagement tools to support field team communication with local payers.
Recommended approach for launching in key local markets, plus…
Outcome: Strategy and insights needed to successfully engage NHS decision-makers and drive change.
We provide strategy and solutions to help Pharma and Medtech companies bring interventions to market, providing more patient choice and meeting the needs of the healthcare environment.
Our consultants and technical experts support global teams and affiliates throughout the product life cycle, from evidence generation and strategy to communication of value.
United Kingdom
Germany
France
Italy
Spain
Canada
USA
Australia
China
Japan
CASE STUDY
Our client’s global market access team were looking for a consultancy who could support them from strategy to implementation. As the client was in the early stages of developing a new product, they first wanted to understand the challenges and opportunities that their new treatment would face when launching in different markets.
Download a PDF brochure and share the Mtech Access story with colleagues
At Mtech Access we are always striving to engage with the wider market access community and share our thoughts on the latest industry issues or methods development.
What is the EU Joint Clinical Assessment (JCA) and what does it mean for market access and reimbursment in Euorpe?
Discover how our symposium brought NHS and industry together to discuss the future of healthcare. We focused on innovation, collaboration, and transformation.
Explore the landscape in key European markets with our free introductory guides
Request your copy of: